MetaCap

Artivion Insider Trades

NYSE: AORTHealth CareMedical/Dental InstrumentsUSD

21.26+0.05 (+0.24%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
40 · $12.06M
Shares bought / sold
0 / 347.56K
Net activity
Net selling $12.1 million

Artivion insider activity

Over the last 12 months, Artivion insiders reported 66 transactions on SEC Form 4: 0 open-market purchases and 40 sales. Insiders bought $0 and sold $12.1 million worth of stock, for net insider selling of $12.1 million. The largest seller was Mackin James P, with $7.4 million in reported sales.

The most recent filing shows GREEN ANDREW M (SVP, Regulatory and Quality) selling 11,480 shares at $24.97 on Sep 10, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AORT's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

AORT insider transactions

Artivion insider transactions
DateInsiderTypeSharesValueFiling
Sep 10, 2026GREEN ANDREW MSVP, Regulatory and QualitySale11,480$286.66KForm 4
Sep 3, 2026GREEN ANDREW MSVP, Regulatory and QualitySale1,493$38.84KForm 4
Sep 2, 2026GREEN ANDREW MSVP, Regulatory and QualitySale6,510$177.50KForm 4
Aug 19, 2026Mackin James PPresident & CEOSale70,000$2.03MForm 4
Aug 14, 2026Berry Lance AEVP, COO, CFO & TreasurerSale715$20.41KForm 4
Aug 14, 2026GREEN ANDREW MSVP, Regulatory and QualitySale616$17.59KForm 4
Aug 12, 2026Holloway Jean FSVP, General CounselSale977$27.83KForm 4
Jun 11, 2026GREEN ANDREW MSVP, Regulatory and QualitySale30,000$620.82KForm 4
Jun 11, 2026GREEN ANDREW MSVP, Regulatory and QualityOption exercise30,000$330.90KForm 4
Jun 11, 2026GREEN ANDREW MSVP, Regulatory and QualitySale14,001$289.92KForm 4
Jun 11, 2026GREEN ANDREW MSVP, Regulatory and QualityOption exercise14,001$258.18KForm 4
Jun 2, 2026SEMEDO ANTHONY B.Directorother6,325—Form 4
Jun 2, 2026SEMEDO ANTHONY B.Directorother6,325—Form 4
May 18, 2026ACKERMAN THOMAS FDirectorAward7,576—Form 4
May 18, 2026BEVEVINO DANIEL JDirectorAward7,576—Form 4
May 18, 2026Bullock JamesDirectorAward7,576—Form 4
May 18, 2026Hoff Elizabeth ADirectorAward7,576—Form 4
May 18, 2026Salveson Jon WDirectorAward7,576—Form 4
May 18, 2026Burbank Jeffrey HDirectorAward7,576—Form 4
May 18, 2026SEMEDO ANTHONY B.DirectorAward7,576—Form 4
May 18, 2026Borgstrom Marna PDirectorAward7,576—Form 4
May 14, 2026Borgstrom Marna PDirectorAward7,850—Form 4
Mar 4, 2026Holloway Jean FSVP, General CounselSale8,962$340.56KForm 4
Mar 3, 2026Berry Lance AEVP, COO, CFO & TreasurerSale6,316$238.59KForm 4
Mar 3, 2026Holloway Jean FSVP, General CounselSale3,843$145.17KForm 4
Mar 3, 2026Stanton Marshall S.SVP, Clinical & MD AffairSale2,149$81.18KForm 4
Mar 3, 2026Mackin James PPresident & CEOSale17,887$675.69KForm 4
Mar 3, 2026Horton AmyVP, Chief Accounting OfficerSale901$34.04KForm 4
Mar 3, 2026Davis John EChief Commercial OfficerSale4,573$172.75KForm 4
Mar 2, 2026Davis John EChief Commercial OfficerSale2,784$105.86KForm 4
Mar 2, 2026Berry Lance AEVP, COO, CFO & TreasurerSale5,178$196.89KForm 4
Mar 2, 2026Holloway Jean FSVP, General CounselSale2,183$83.01KForm 4
Mar 2, 2026Mackin James PPresident & CEOSale14,911$566.99KForm 4
Mar 2, 2026Horton AmyVP, Chief Accounting OfficerSale641$24.37KForm 4
Mar 2, 2026Stanton Marshall S.SVP, Clinical & MD AffairSale1,513$57.53KForm 4
Mar 2, 2026Berry Lance AEVP, COO, CFO & TreasurerAward40,874—Form 4
Mar 2, 2026Holloway Jean FSVP, General CounselAward27,795—Form 4
Mar 2, 2026Stanton Marshall S.SVP, Clinical & MD AffairAward21,838—Form 4
Mar 2, 2026Mackin James PPresident & CEOAward116,948—Form 4
Mar 2, 2026Horton AmyVP, Chief Accounting OfficerAward7,475—Form 4
Mar 2, 2026Davis John EChief Commercial OfficerAward28,845—Form 4
Feb 24, 2026Davis John EChief Commercial OfficerAward20,438—Form 4
Feb 24, 2026Davis John EChief Commercial OfficerSale2,075$74.06KForm 4
Feb 24, 2026Berry Lance AEVP, COO, CFO & TreasurerAward37,482—Form 4
Feb 24, 2026Berry Lance AEVP, COO, CFO & TreasurerSale4,485$160.08KForm 4
Feb 24, 2026Mackin James PPresident & CEOAward97,030—Form 4
Feb 24, 2026Mackin James PPresident & CEOSale13,936$497.42KForm 4
Feb 24, 2026Stanton Marshall S.SVP, Clinical & MD AffairSale1,259$44.94KForm 4
Feb 24, 2026Holloway Jean FSVP, General CounselAward20,085—Form 4
Feb 24, 2026Holloway Jean FSVP, General CounselSale1,668$59.54KForm 4
Feb 24, 2026Horton AmyVP, Chief Accounting OfficerAward5,658—Form 4
Feb 24, 2026Horton AmyVP, Chief Accounting OfficerSale830$29.63KForm 4
Feb 23, 2026Davis John EChief Commercial OfficerSale3,773$141.82KForm 4
Feb 23, 2026Berry Lance AEVP, COO, CFO & TreasurerSale4,981$187.23KForm 4
Feb 23, 2026Mackin James PPresident & CEOSale20,962$787.92KForm 4
Feb 23, 2026Stanton Marshall S.SVP, Clinical & MD AffairSale2,423$91.08KForm 4
Feb 23, 2026Holloway Jean FSVP, General CounselSale3,079$115.73KForm 4
Feb 23, 2026Horton AmyVP, Chief Accounting OfficerSale1,731$65.06KForm 4
Dec 15, 2025Davis John EChief Commercial OfficerSale5,000$225.55KForm 4
Dec 8, 2025Horton AmyVP, Chief Accounting OfficerSale4,572$203.08KForm 4
Dec 3, 2025Holloway Jean FSVP, General CounselSale5,267$238.60KForm 4
Dec 3, 2025Holloway Jean FSVP, General CounselSale2,048$92.77KForm 4
Dec 3, 2025Mackin James PPresident & CEOSale30,921$1.41MForm 4
Dec 3, 2025Mackin James PPresident & CEOOption exercise30,921$915.88KForm 4
Dec 2, 2025Mackin James PPresident & CEOSale30,921$1.41MForm 4
Dec 2, 2025Mackin James PPresident & CEOOption exercise30,921$915.88KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related